138 related articles for article (PubMed ID: 90060)
21. Monoclonal anti-HLA-B27 antibody (B27M1): production and lack of detectable typing difference between patients with ankylosing spondylitis, Reiter's syndrome, and normal controls.
Grumet FC; Fendly BM; Engleman EG
Lancet; 1981 Jul; 2(8239):174-6. PubMed ID: 6166821
[No Abstract] [Full Text] [Related]
22. Public epitopes and the antigenic structure of the HLA molecules.
Rodey GE; Fuller TC
Crit Rev Immunol; 1987; 7(3):229-67. PubMed ID: 2441930
[TBL] [Abstract][Full Text] [Related]
23. Molecular mimicry in Reiter's syndrome: cytotoxicity and ELISA studies of HLA-microbial relationships.
Inman RD; Chiu B; Johnston ME; Falk J
Immunology; 1986 Jul; 58(3):501-6. PubMed ID: 3488263
[TBL] [Abstract][Full Text] [Related]
24. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
Georgopoulos K; Dick WC; Goodacre JA; Pain RH
Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
[TBL] [Abstract][Full Text] [Related]
25. [Clinical relations of certain HLA-B 27 positive disease pictures].
Mathies H
Fortschr Med; 1983 Oct; 101(37):1667-8. PubMed ID: 6605905
[No Abstract] [Full Text] [Related]
26. Primary structure of papain-solubilized human histocompatibility antigen HLA-B27.
Ezquerra A; Bragado R; Vega MA; Strominger JL; Woody J; López de Castro JA
Biochemistry; 1985 Mar; 24(7):1733-41. PubMed ID: 2408663
[TBL] [Abstract][Full Text] [Related]
27. A reanalysis of the HLA-B7 cross-reactive group.
Darke C
Tissue Antigens; 1983 Nov; 22(5):326-34. PubMed ID: 6606863
[TBL] [Abstract][Full Text] [Related]
28. Genetic aspects of ankylosing spondylitis.
Khan MA; Ball EJ
Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):675-90. PubMed ID: 12406434
[TBL] [Abstract][Full Text] [Related]
29. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
[TBL] [Abstract][Full Text] [Related]
30. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
[TBL] [Abstract][Full Text] [Related]
31. Murine H-2Dd-reactive monoclonal antibodies recognize shared antigenic determinant(s) on human HLA-B7 or HLA-B27 molecules or both.
Rebai N; Mercier P; Kristensen T; Devaux C; Malissen B; Mawas C; Pierres M
Immunogenetics; 1983; 17(4):357-70. PubMed ID: 6187678
[TBL] [Abstract][Full Text] [Related]
32. Undifferentiated spondyloarthropathies in Brazilians: importance of HLA-B27 and the B7-CREG alleles in characterization and disease progression.
Sampaio-Barros PD; Conde RA; Donadi EA; Kraemer MH; Persoli L; Coimbra IB; Costallat LT; Samara AM; Bértolo MB
J Rheumatol; 2003 Dec; 30(12):2632-7. PubMed ID: 14719206
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT).
Neumüller J; Schwartz DW; Dauber E; Mayr WR
Cytometry; 1996 Sep; 26(3):209-15. PubMed ID: 8889393
[TBL] [Abstract][Full Text] [Related]
34. Immunochemical variants of HLA-B27.
Kaneoka H; Engleman EG; Grumet FC
J Immunol; 1983 Mar; 130(3):1288-92. PubMed ID: 6600481
[TBL] [Abstract][Full Text] [Related]
35. Characterization of HLA-Bw73 by serology and one-dimensional isoelectric focusing patterns.
Eynon EE; Yang SY; Cronin CR; Alosco SM; Alper CA; Yunis EJ
Hum Immunol; 1986 Aug; 16(4):356-63. PubMed ID: 2428782
[TBL] [Abstract][Full Text] [Related]
36. HLA-B specificities and w4, w6 specificities are on the same polypeptide.
Ayres J; Cresswell P
Eur J Immunol; 1976 Nov; 6(11):794-9. PubMed ID: 63373
[TBL] [Abstract][Full Text] [Related]
37. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
Darke C
Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
[TBL] [Abstract][Full Text] [Related]
38. [Human major histocompatibility complex: the HLA system].
Charron D; Khalil I
Rev Prat; 1994 Jan; 44(1):20-7. PubMed ID: 8178053
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
de Rooij-Doyer E; Bruning JW; van Rood JJ
Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
[TBL] [Abstract][Full Text] [Related]
40. HLA-B POT: a new HLA-antigen within the B7-cross reactive group.
Reekers P; van der Beucken M; Andrien M; Beelen J; Mueller-Eckhardt G; Schreuder GM
Tissue Antigens; 1986 Sep; 28(3):182-9. PubMed ID: 2431514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
